Related Topics
     

    Nienhuis: News Releases & Feature Stories

     
    09/19/2012
    A Giant Step for Gene Therapy

    Exciting gene therapy study helps patients with hemophilia B.

     
     
    11/02/2009
    Hematologist Arthur Nienhuis named 2009 ASH Mentor Award recipient

    Arthur Nienhuis, M.D., of St. Jude Children’s Research Hospital, is the recipient of the 2009 Mentor Award from the American Society of Hematology (ASH).

     
     
    12/10/2004
    New leadership at St. Jude

    Former St. Jude Director Arthur W. Nienhuis, M.D., and George Simon, chair of the St. Jude Board of Governors, recently announced that William E. Evans, Pharm.D., assumed the position of St. Jude Director and CEO. Nov. 1, 2004.

     
     
    05/01/2003
    St. Jude researchers reverse blood disease using genetically modified stem cells

    Researchers at St. Jude Children's Research Hospital have overcome two major technical obstacles that currently limit the success of gene therapy for human red blood cell diseases such as beta-thalassemia and sickle cell disease.

     
     
    10/18/2002
    St. Jude faculty elected to Institute of Medicine

    Arthur Nienhuis, M.D., and William Evans, Pharm.D., of St. Jude Children's Research Hospital have been elected to the Institute of Medicine, a prestigious branch of the National Academy of Sciences.